Board MeetingOutcome of Board Meeting
Neuland Labs' Board approved FY26 consolidated results: Revenue ₹2022.98 Cr, Profit ₹363.99 Cr, EPS ₹283.71. A final dividend of ₹34/share was proposed.
Neuland Laboratories LimitedNEULANDLAB · Filed with the exchange
Dr. Mauricio Futran appointed as Additional Director.
Capacity at Unit 1 will expand by 120.5 KL with ₹143.4 Cr investment.
AGM on Aug 4, 2026.
No comments yet. Be the first.